Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients

BACKGROUND: This study aims to better define prognostic factors for patients with metastatic urothelial carcinoma (mUC), and to identify patients who will benefit from first-line cisplatin-based chemotherapy. We test the hypothesis that early objective response (EOR), defined as the occurrence of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Roubaud, Guilhem, Brouste, Véronique, Beuzeboc, Phillipe, Fléchon, Aude, Tosi, Diego, Lavau-Denes, Sandrine, Chevreau, Christine, Culine, Stéphane, Oudard, Stéphane, Quivy, Amandine, Pourquier, Philippe, Houédé, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641378/
https://www.ncbi.nlm.nih.gov/pubmed/26555878
http://dx.doi.org/10.1186/s12952-015-0037-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641378/
https://www.ncbi.nlm.nih.gov/pubmed/26555878
http://dx.doi.org/10.1186/s12952-015-0037-5

Ejemplares similares